One year after launching the CMS Health Tech Ecosystem, officials convened in D.C. to celebrate the Trump administration modernizing health technology.
Biotech companies are racing to cure alpha-1 antitrypsin deficiency, AATD, fueling patent disputes, startup defections, arbitration, and a U.S.-China rivalry.
The big takeaway from the recent Alzheimer’s Association International Conference in London is an economic message: Dementia finally has a business model, writes Jason Karlawish.
Lakshmi Halasyamani, chief clinical officer at Endeavor Health, thinks value-based care isn’t really about payment models. To her, this work centers on understanding patients’ clinical, social and financial circumstances well enough to make care plans that actually work for their lives. The post Why Endeavor Health Refuses to Silo Its Value-Based Care Strategy appeared first on MedCity News .
Argenx’s first acquisition is the buyout of Forte Biosciences, a company with a lead drug that has early clinical validation in celiac disease and vitiligo. Argenx executives say this antibody complements its blockbuster product Vyvgart, offering a different mechanism of action but similar pipeline-in-a-product potential. The post Argenx’s $2B Forte Bio Acquisition Brings Autoimmune Playbook to Prevalent Disorders appeared first on MedCity News .
The world risks a resurgence of the HIV epidemic after international financing to combat the disease suffered a “profound shock” last year, according to a new report from UNAIDS.
Sen. Rand Paul has released a tranche of Dr. Anthony Fauci's diary entries from the COVID-19 pandemic. Fauci is set to appear before a Senate committee Wednesday on the origins of the coronavirus.
(MedPage Today) -- FDA scientists said that investigational deramiocel, a stem cell treatment for Duchenne muscular dystrophy, did not meet its primary endpoint in a phase III trial, despite data presented at the American Academy of Neurology ...
(MedPage Today) -- Hypofractionated locoregional radiotherapy for high-risk breast cancer was noninferior to standard fractionated radiotherapy for the 3-year incidence of arm lymphedema, with no significant differences in cancer outcomes, a Danish...
(MedPage Today) -- The office of Sen. Mitch McConnell (R-Ky.) released an update on his health Monday, this time with a statement from the congressional Office of Attending Physician stating the senator has not yet been medically cleared to leave...